-
SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.USD↓
Mitarbeiter
34.300
Die letzten Quartalsergebnisse Erwarteter Gewinn je Aktie beim aktuellen Wert von
Dir gefallen die Informationen zu Bristol-Myers Squibb Company?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:
Zu Trade Republic
Dir gefallen die Informationen zu Bristol-Myers Squibb Company?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:
Zu BUX Zero
Dir gefallen die Informationen zu Bristol-Myers Squibb Company?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:
Zur ING Diba
Dir gefallen die Informationen zu Bristol-Myers Squibb Company?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:
Zur Comdirect
95 News & Informationen zur Bristol-Myers Squibb Company Aktie
10 Best Psychedelic Stocks to Buy Now
In this article, we discuss the 10 best psychedelic stocks to buy now. If you want to skip our detailed analysis of these stocks, go directly to the 5…
Oak Harvest Investment Services Buys Advanced Micro Devices Inc, Amazon.com Inc, Square Inc, Sells Akamai Technologies Inc, Bristol-Myers Squibb Company, Qualcomm Inc
GuruFocus Article or News written by insider and the topic is about:
Valuation in Geriatric Medicines Market to Reach US$ 1142.8 Bn by 2027, Use in Managing Cardiovascular Diseases Spurs Growth: TMR
/PRNewswire/ — Geriatrics care has made enormous strides over the past few decades. Rapidly aging populations notably in some emerging economies and developed…
Valuation In Geriatric Medicines Market To Reach US$ 1142.8 Bn By 2027, Use In Managing Cardiovascular Diseases Spurs Growth: TMR
ALBANY, N.Y., July 12, 2021 /PRNewswire/ — Geriatrics care has made enormous strides over the past few decades. Rapidly aging populations notably in some
2 Biotech IPO Stocks You'll Want to Have on Your Radar
They have promising pipeline candidates and should go public soon.
Can Gilead Beat Bristol Myers Squibb With Its Cancer CAR-T Therapy?
The battle for market share could come down to which drug has the lesser side effects.
Bristol Myers Squibb (BMY) Gains But Lags Market: What You Should Know
Bristol Myers Squibb (BMY) closed the most recent trading day at $67.16, moving +0.7% from the previous trading session.
Bristol-Myers Squibb Stock Is A High Yielding Blue-Chip (NYSE:BMY)
Bristol-Myers Squibb stock appears ready for a new valuation and trading range, where the low to mid $60s should provide support.
Bristol Myers Squibb (BMY) Stock Moves -0.67%: What You Should Know
Bristol Myers Squibb (BMY) closed at $66.69 in the latest trading session, marking a -0.67% move from the prior day.
Hikari Power Ltd Buys AbbVie Inc, Merck Inc, Vanguard Health Care ETF, Sells Wells Fargo, Nutrien, Cisco Systems Inc
GuruFocus Article or News written by insider and the topic is about:
Helius Medical Technologies, Inc. Appoints Antonella Favit-Van Pelt, M.D., Ph.D. as Chief Medical Officer
NEWTOWN, Pa., July 08, 2021 (GLOBE NEWSWIRE) — Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company…
Helius Medical Technologies, Inc. Appoints Antonella Favit-Van Pelt, M.D., Ph.D. as Chief Medical Officer
NEWTOWN, Pa., July 08, 2021 — Helius Medical Technologies, Inc. , a neurotech company focused on neurological wellness, today announced the appointment of Antonella Favit-Van Pelt, M.D.,… | July 8, 2021
Ikena Oncology To Participate In Targeted Oncology Panel At The William Blair Biotech Focus Conference 2021
BOSTON, July 08, 2021 (GLOBE NEWSWIRE) — Ikena Oncology, Inc. (Nasdaq: IKNA), a targeted oncology company focused on developing therapies targeting key
Global Anticoagulants Market (2021 to 2026) – by Drug Class, Route of Administration and Geography
DUBLIN, July 7, 2021 /PRNewswire/ — The 'Global Anticoagulants Market (2021-2026) by Drug Class, Route of Administration, Geography and the Impac…
The Worldwide Precision Medicine Industry is Expected to Reach $738.8 Billion by 2030
DUBLIN, July 7, 2021 /PRNewswire/ — The 'Precision Medicine Market Research Report: By Type (Therapeutics, Diagnostics, Personalized Medical Care…
Hot Small-Cap Stocks To Watch With Potential Cancer Breakthroughs
10 Psychedelic Startups Investors are Flocking To
In this article, we discuss the 10 psychedelic startups investors are flocking to. If you want to skip our detailed analysis of these startups, go directly…
3 Dividend Stocks That Are Dirt Cheap Right Now
Most stocks are priced at a premium. But these are bargains that also offer solid dividends.
Global Pulmonary Arterial Hypertension Market (2021 to 2026) – by Drug Class, Route of Administration, Distribution Mode and Geography
/PRNewswire/ — The “Global Pulmonary Arterial Hypertension Market (2021-2026) by Drug Class, Route of Administration, Distribution Mode, Geography,…
Bristol Myers Squibb (BMY) Gains But Lags Market: What You Should Know
In the latest trading session, Bristol Myers Squibb (BMY) closed at $66.95, marking a +0.59% move from the previous day.
Bristol Myers Squibb (BMY) Stock Sinks As Market Gains: What You Should Know
Bristol Myers Squibb (BMY) closed at $66.56 in the latest trading session, marking a -0.39% move from the prior day.
Gene Therapy Market to Grow Substantially at 40.7% CAGR by 2025 – Report by Market Research Future (MRFR)
Gene Therapy Market Insights and Industry Analysis by Indication (Genetic Diseases, Oncology), By End-User (Hospitals & Clinics, Specialty Treatment…
Antibiotics Market Size Worth USD 64,532 Million by 2025 at 4.8% CAGR – Report by Market Research Future (MRFR)
Antibiotics Market Insights and Industry Analysis by Spectrum of Activity (Broad-spectrum Antibiotic, Narrow-spectrum Antibiotic), Drug Class…
Global Mobile Medical Apps Market to Reach $16.5 Billion by 2026
/PRNewswire/ — A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled…
3 Pharma Stocks with Tremendous Growth Potential By StockNews
3 Pharma Stocks with Tremendous Growth Potential
Compugen Doses First Patient In COM701/Opdivo® (nivolumab) Phase 1b Cohort Expansion Study
HOLON, Israel, June 30, 2021 /PRNewswire/ — Compugen Ltd. CGEN, a clinical-stage cancer immunotherapy company and a leader in predictive target discovery,
Global Glioblastoma Multiforme (GBM) Treatment Market Could Reach Nearly $1.8 Billion By 2027
/PRNewswire/ — Glioblastoma multiforme (GBM) is one of the areas where the research & development investments are high and where global studies are growing….
3 Huge Monthly Dividends Set To Soar (One Yields An Incredible 7.6%)
Stocks Analysis by Contrarian Outlook (Brett Owens) covering: S&P 500, SPDR® S&P 500, iShares Biotechnology ETF, Amazon.com Inc. Read Contrarian Outlook (Brett Owens)'s latest article on Investing.com
16 Best Beginner Stocks to Invest in Right Now
In this article we will take a look at the 16 best beginner stocks to invest in right now. You can skip our detailed analysis of these stocks, and go…
5 Buffett Stocks to Buy Hand Over Fist for the Second Half of 2021
These growth and value stocks are begging to be bought by investors.
Bristol Myers Squibb (BMY) Outpaces Stock Market Gains: What You Should Know
In the latest trading session, Bristol Myers Squibb (BMY) closed at $66.74, marking a +1.35% move from the previous day.
2 Healthcare Stocks That Could Grow Your Portfolio By StockNews
2 Healthcare Stocks That Could Grow Your Portfolio
The Worldwide Cryptococcosis Treatment Industry is Expected to Reach $6 Billion by 2026 at a CAGR of 4.5% from 2021
/PRNewswire/ — The “Global Cryptococcosis Treatment Market (2021-2026) byTreatment, Distribution Channel, Geography and the Impact of COVID-19 with Ansoff…
The Worldwide Cryptococcosis Treatment Industry is Expected to Reach $6 Billion by 2026 at a CAGR of 4.5% from 2021
/PRNewswire/ — The “Global Cryptococcosis Treatment Market (2021-2026) byTreatment, Distribution Channel, Geography and the Impact of COVID-19 with Ansoff…
The Worldwide Cryptococcosis Treatment Industry is Expected to Reach $6 Billion by 2026 at a CAGR of 4.5% from 2021
/PRNewswire/ — The “Global Cryptococcosis Treatment Market (2021-2026) byTreatment, Distribution Channel, Geography and the Impact of COVID-19 with Ansoff…
The Worldwide Cryptococcosis Treatment Industry is Expected to Reach $6 Billion by 2026 at a CAGR of 4.5% from 2021
/PRNewswire/ — The “Global Cryptococcosis Treatment Market (2021-2026) byTreatment, Distribution Channel, Geography and the Impact of COVID-19 with Ansoff…
The Worldwide Cryptococcosis Treatment Industry is Expected to Reach $6 Billion by 2026 at a CAGR of 4.5% from 2021
/PRNewswire/ — The “Global Cryptococcosis Treatment Market (2021-2026) byTreatment, Distribution Channel, Geography and the Impact of COVID-19 with Ansoff…
How Will the Drop in Biogen’s Share Price Hit Buffett’s Portfolio? – 24
One of six drugmakers in Berkshire Hathaway's portfolio, dropped by more than 6% on Thursday, but it remains the best performer of the six investments.
Bristol Myers Squibb : Receives Positive CHMP Opinion for Opdivo (nivolumab) as Adjuvant Treatment for Esophageal or Gastroesophageal Junction Cancer Patients with Residual Pathologic Disease Followin
Recommendation based on positive results from the Phase 3 CheckMate -577 trial in which Opdivo doubled disease-free survival compared to placebo in the all-randomized population
If approved, Opdivo… | June 25, 2021
Bristol Myers Squibb (BMY) Dips More Than Broader Markets: What You Should Know
Bristol Myers Squibb (BMY) closed at $65.26 in the latest trading session, marking a -1.03% move from the prior day.